The impact of national centralized drug procurement on health expenditures for lung cancer inpatients: A difference-in-differences analysis in a large tertiary hospital in China

• Главные авторы: Yuan-jin Zhang (Автор), Yan Ren (Автор), Quan Zheng (Автор), Jing Tan (Автор), Ming-hong Yao (Автор), Yun-xiang Huang (Автор), Xia Zhang (Автор), Kang Zou (Автор), Shao-yang Zhao (Автор), Xin Sun (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

The availability and affordability of medicines remain major health challenges around the world. In March 2019, the Chinese government introduced a pilot National Centralized Drug Procurement (NCDP) program in order to reduce drug prices and improve the affordability of effective and safe medicines....